A new vaccine against nicotine addiction
One dose of a new gene therapy vaccine for life relieves mice of nicotine addiction, turning their liver into a factory for the production of antibodies against nicotine.
29.06.2012One dose of a new gene therapy vaccine for life relieves mice of nicotine addiction, turning their liver into a factory for the production of antibodies against nicotine.
29.06.2012Cornell University researchers have developed two vaccines that use different mechanisms to stimulate the production of antibodies that block cocaine molecules before they enter the brain.
26.06.2012Hiding "on the back" of red blood cells, the virus is not destroyed by the immune system, affects only cancer cells and stimulates an immune attack on infected and uninfected tumor cells and metastases.
14.06.2012Researchers from the Weizmann Institute have synthesized a small peptide that replaces a protein with a command about unlimited division, preventing it from reaching the nucleus of a cancer cell.
13.06.2012The effectiveness of the synthetic vaccine in the fight against oncological diseases caused by papillomavirus, which leads to cervical cancer and, less often, head and neck cancer, has been confirmed in mice.
13.06.2012During three years of testing a new therapeutic vaccine against Alzheimer's disease, 80% of patients produced their own antibodies against beta-amyloid without any side effects.
09.06.2012AFFiRiS AG has announced the launch of the world's first clinical trial of a therapeutic vaccine against Parkinson's disease.
07.06.2012The proteins created with the help of computer modeling are combined with hemagglutinin located on the surface of influenza viruses, like a key with a lock, and their antiviral potential is no less effective than that of monoclonal antibodies.
07.06.2012To deliver small interfering RNAs (miRNAs) that inhibit the synthesis of a certain protein to tumor cells, they were packed into nanocontainers created on the principle of DNA origami.
05.06.2012The Laboratory of Supercomputer Technologies for Biomedicine, Pharmacology and Small-sized Structures I-SCALARE presented new research results in the field of bioinformatics and drug modeling.
31.05.2012The first meeting within the framework of the Scientific Cafe project, which brought together more than 150 young specialists and leading students of Moscow universities, was devoted to biomedicine.
30.05.2012The drug based on the pro-inflammatory enzyme plasminogen is able to initiate and accelerate the healing of wounds and diabetic ulcers.
29.05.2012A drug for the treatment of schizophrenia symptoms, tens of times enhancing the effectiveness of a standard drug against acute myeloid leukemia, helps to destroy cancer stem cells and prevent relapses of the disease.
25.05.2012Long before the symptoms of Parkinson's disease appear, its molecular marker, alpha–synuclein, can be detected in intestinal cells obtained during colonoscopy.
25.05.2012The emergence of personalized antitumor drugs has led some oncologists to think about the need to revise the strategy of conducting clinical trials in this area.
23.05.2012A personal medicine designed for a specific person is a myth. Personalized medicine focuses not on one patient or even hundreds of patients, but on subpopulations.
17.05.2012The drug crenezumab is an antibody specific to the beta-amyloid protein. Its clusters – amyloid plaques – are formed in the brains of people suffering from Alzheimer's disease.
17.05.2012Modified T-cell receptors can selectively bind to tumor cells, marking them for destruction by T-lymphocytes, normally reacting to microorganisms, and not to cancer cells.
10.05.2012The authors of the technique hope that this is only the beginning of understanding the contribution of epigenetics to the development of breast cancer, and in the coming years they expect to find many more examples of the effect of gene modification on the risk of developing various diseases.
05.05.2012The first epigenetic antitumor drug of its kind was recognized as safe during the phase I clinical trial.
03.05.2012You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.